Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$915M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$576M |
| 3 |
NVIDIA
NVDA
|
+$355M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$321M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$991M |
| 2 |
Cigna
CI
|
+$435M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$432M |
| 4 |
Medtronic
MDT
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 10.89% |
| 3 | Healthcare | 10.04% |
| 4 | Industrials | 8.79% |
| 5 | Consumer Discretionary | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
iShares Europe ETF
IEV
$1.7B
| $1.28M | ﹤0.01% |
24,150
-7,240
| -23% | -$357K |
|
|
FFIC
3027
DELISTED
Flushing Financial
FFIC
| $1.27M | ﹤0.01% |
76,921
+11,505
| +18% | +$160K |
|
3028
Vanda Pharmaceuticals
VNDA
$302M
| $1.26M | ﹤0.01% |
299,223
-330,927
| -53% | -$1.34M |
|
|
DCPH
3029
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.26M | ﹤0.01% |
78,165
-48,644
| -38% | -$621K |
|
|
CASA
3030
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $1.26M | ﹤0.01% |
2,375,321
+17,095
| +0.7% | +$9.28K |
|
3031
PetMed Express
PETS
$42.3M
| $1.26M | ﹤0.01% |
166,482
+114,100
| +218% | +$937K |
|
3032
Tredegar Corp
TG
$310M
| $1.25M | ﹤0.01% |
231,528
+104,128
| +82% | +$514K |
|
|
EHI
3033
Western Asset Global High Income Fund
EHI
$178M
| $1.25M | ﹤0.01% |
173,427
+32,377
| +23% | +$215K |
|
3034
Horizon Bancorp
HBNC
$1.04B
| $1.25M | ﹤0.01% |
87,397
-35,416
| -29% | -$400K |
|
|
SPWR
3035
DELISTED
SunPower Corporation Common Stock
SPWR
| $1.24M | ﹤0.01% |
256,384
-27,359
| -10% | -$131K |
|
3036
Perella Weinberg Partners
PWP
$1.3B
| $1.24M | ﹤0.01% |
101,133
+18,013
| +22% | +$196K |
|
|
AUGX
3037
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $1.23M | ﹤0.01% |
210,531
-32,099
| -13% | -$169K |
|
3038
Jakks Pacific
JAKK
$293M
| $1.23M | ﹤0.01% |
34,633
| – | – |
|
3039
Invesco Municipal Opportunity Trust
VMO
$663M
| $1.23M | ﹤0.01% |
127,989
+68,233
| +114% | +$598K |
|
3040
Saratoga Investment
SAR
$322M
| $1.23M | ﹤0.01% |
47,463
+555
| +1% | +$13.9K |
|
|
AFCG
3041
AFC Gamma
AFCG
$63.4M
| $1.23M | ﹤0.01% |
149,113
+9,718
| +7% | +$76.6K |
|
3042
Vaalco Energy
EGY
$594M
| $1.23M | ﹤0.01% |
+272,900
| New | +$1.2M |
|
3043
Xeris Biopharma Holdings
XERS
$1.37B
| $1.22M | ﹤0.01% |
520,121
-67,817
| -12% | -$125K |
|
3044
V2X
VVX
$2.65B
| $1.22M | ﹤0.01% |
26,305
+9,513
| +57% | +$448K |
|
3045
Washington Trust Bancorp
WASH
$741M
| $1.22M | ﹤0.01% |
37,646
+6,070
| +19% | +$165K |
|
|
PFC
3046
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.2M | ﹤0.01% |
49,948
+90
| +0.2% | +$1.78K |
|
3047
AerSale
ASLE
$279M
| $1.2M | ﹤0.01% |
94,152
+19,054
| +25% | +$277K |
|
|
ASGI
3048
abrdn Global Infrastructure Income Fund
ASGI
$766M
| $1.19M | ﹤0.01% |
66,585
-9,135
| -12% | -$151K |
|
3049
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.36B
| $1.19M | ﹤0.01% |
13,677
-10
| -0.1% | -$793 |
|
|
ETO
3050
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$520M
| $1.19M | ﹤0.01% |
50,266
+1,777
| +4% | +$39K |
|
Similar funds
Ameriprise's Q4 2023 Portfolio in Review
As of Q4 2023, Ameriprise held 4,040 positions worth $334B, up 9.7% from $305B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ameriprise's Q4 2023 filing shows 156 new, 1,686 increased, 1,943 reduced and 146 closed positions. Its largest new stake was Pacer US Small Cap Cash Cows 100 ETF: 647,103 shares worth $31M. The largest sale was Broadcom, an estimated $991M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2023 buy was Pacer US Small Cap Cash Cows 100 ETF: 647,103 shares worth $31M.
- Ameriprise added most to iShares Russell 1000 Growth ETF in Q4 2023, an estimated $915M increase.
- Ameriprise's biggest Q4 2023 reduction was Broadcom, cutting an estimated $991M.
- Ameriprise fully exited Activision Blizzard in Q4 2023, selling an estimated $374M.
- Ameriprise's ten largest holdings make up 17% of its $334B portfolio in Q4 2023.
- Ameriprise opened 156 new positions and closed 146 in Q4 2023.
- Ameriprise's portfolio value rose 9.7% quarter-over-quarter to $334B.
Based on Ameriprise's 13F filing for Q4 2023, filed 14 Feb 2024.